Therapeutic Thursdays: DOAC-Related Bleeding Reversed, Now What?

The management of patients with major/life-threatening bleeding related to the use of direct-acting oral anticoagulants does not stop with reversal of the anticoagulant. Learn from the perspective of a neurocritical care pharmacy specialist about considerations in providing comprehensive care and continued assessment to patients after these bleeding events. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.